8110.F 111 INC. ADR/20 CL.A
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is 8110.F undervalued?
Graham numberThe Graham number of 111 INC. ADR/20 CL.A cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
111 INC. ADR/20 CL.A fundamental analysis
No fundamental analysis for 111 INC. ADR/20 CL.A yet.
111 INC. ADR/20 CL.A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About 111 INC. ADR/20 CL.A
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services. It also …
Full company profileFinancial statements of 111 INC. ADR/20 CL.A are not available yet.
111 INC. ADR/20 CL.A dividends
111 INC. ADR/20 CL.A has not paid dividends in the last 2 fiscal years.
Last stock split: 0.1:1 on Jan 24, 2025.
Who owns 111 INC. ADR/20 CL.A
- Insiders 46.47%
- Institutions 0.68%
- Public & others 52.85%
- Free float 4.66M
111 INC. ADR/20 CL.A company profile
- Company name
- 111 INC. ADR/20 CL.A
- Ticker
- 8110.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Medical Distribution
- Employees
- 1,063
- Fiscal year end
- December
- Address
- No.295 ZuChongZhi Road, Shanghai, China, 201203
- Phone
- 86 21 2053 6666
- Website
- corporate.111.com.cn
About 111 INC. ADR/20 CL.A
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services. It also provides 1 Pharmacy online wholesale pharmacy that offers pharmaceutical and other health and wellness products; and 1 Medicine Marketplace online retail pharmacy that provides drugs, nutritional supplements, medical supplies and devices, personal care, and baby products. In addition, the company offers online loan application services; cloud-based inventory management services; smart procurement services, which collect pharmacies' historical purchase orders and inventory data; and Hawkeye automated salesforce tool, as well as online consultation, e-prescription, and data services. Further, its pharmacies provide drugs, including prescription and over-the-counter drugs comprising Western and Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices that consists of bandages and thermometers; and personal care products that include skin care, birth control, sexual wellness, and baby products. Additionally, the company offers research and development, and consulting services; warehousing, procurement, and logistics services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies, medical professionals, and marketplace sellers. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
111 INC. ADR/20 CL.A management
5- Dr. Gang Yu Ph.D.Co-Founder & Executive Chairman · born 1959
- Mr. Junling LiuCo-Founder, Acting CFO, Chairman & CEO · born 1965
- Monica MuIR Director
- Mr. Anfeng GuoChief Innovation Officer
- Mr. Alex LiuFinance Director